Corbus Pharmaceuticals Holdings (CRBP) Non-cash Items (2014 - 2025)

Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Non-cash Items of $371000.0 in Q4 2025, up 10779.77% quarter-over-quarter from $3410.0 in Q3 2025, and down 57.89% on a YoY basis from $881000.0 in Q4 2024.

Corbus Pharmaceuticals Holdings (CRBP) Non-cash Items (2014 - 2025) Analysis & Trends

Corbus Pharmaceuticals Holdings' Non-cash Items history runs 12 years deep, the most recent figure standing at $371000.0 for Q4 2025.

  • In Q4 2025, Non-cash Items fell 57.89% year-over-year to $371000.0; the TTM figure through Dec 2025 stood at $371000.0 (down 57.89% YoY), while the FY2025 annual figure was $371000.0, down 57.89% from the prior year.
  • Non-cash Items was $371000.0 for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $3410.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $38.8 million in Q3 2021 to a low of $312.0 in Q2 2025.
  • Historically, Non-cash Items has averaged $12.6 million across 5 years, with a median of $10.6 million in 2022.
  • The sharpest annual moves came in 2021 and 2025: Non-cash Items soared 157.42% in 2021, then slumped 99.92% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $9.0 million in 2021, then advanced by 24.25% to $11.2 million in 2022, then surged by 80.57% to $20.2 million in 2023, then tumbled by 95.64% to $881000.0 in 2024, then slumped by 57.89% to $371000.0 in 2025.
  • The last three Non-cash Items figures came in at $371000.0 (Q4 2025), $3410.0 (Q3 2025), and $312.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Corbus Pharmaceuticals Holdings 136.49 Mn 108.68 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 371,000.00
Dec 31, 2025 371,000.00
Sep 30, 2025 3,410.00
Sep 30, 2025 3,410.00
Jun 30, 2025 312.00
Jun 30, 2025 312.00
Mar 31, 2025 451,340.00
Mar 31, 2025 451,340.00
Dec 31, 2024 881,000.00
Dec 31, 2024 881,000.00
Sep 30, 2024 389,369.00
Sep 30, 2024 389,369.00
Jun 30, 2024 370,025.00
Jun 30, 2024 370,025.00
Mar 31, 2024 432,919.00
Mar 31, 2024 432,919.00
Dec 31, 2023 20.22 Mn
Dec 31, 2023 20.22 Mn
Sep 30, 2023 20.82 Mn
Sep 30, 2023 20.82 Mn